Acadian Asset Management LLC Biocept Inc Transaction History

Acadian Asset Management LLC

  • $32.5 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 09, 2022
SELL
$0.88 - $2.27 $11,185 - $28,853
-12,711 Reduced 47.82%
13,871 $13,000
Q1 2022

May 12, 2022
SELL
$1.83 - $3.97 $65,398 - $141,875
-35,737 Reduced 57.35%
26,582 $61,000
Q4 2021

Feb 10, 2022
BUY
$3.43 - $4.22 $213,754 - $262,986
62,319 New
62,319 $225,000

About BIOCEPT INC

BIOC Quotes by TradingView
  • Ticker BIOC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 16,922,900
  • Market Cap $1.18M
  • Description
  • Biocept, Inc., a molecular oncology diagnostics company, develops and commercializes proprietary circulating tumor cell and circulating cell-free tumor DNA and RNA assays utilizing a standard blood sample. Its cancer assays provide information to healthcare providers to identify oncogenic alterations that qualify a subset of cancer patients for ...
More about BIOC
Track This Portfolio

Track Acadian Asset Management LLC Portfolio

Follow Acadian Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email